/Companies

Atterx

2 known investors

Find your way into Atterx

Sign up to see every warm intro you have to Atterx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Atterx team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atterx develops novel pharmaceutical therapies to prevent and treat antibiotic-resistant bacterial infections using bacterial interference and conjugation technologies. The company targets multi-drug resistant infections through specialty pharmaceutical products designed for clinical development.

Founders & leadership

JM
James MillarChief Executive Officer

Investors · 2

Frequently asked questions

What does Atterx do?
Atterx develops novel pharmaceutical therapies to prevent and treat antibiotic-resistant bacterial infections using bacterial interference and conjugation technologies. The company targets multi-drug resistant infections through specialty pharmaceutical products designed for clinical development.
Who are Atterx's investors?
Atterx's investors include Michigan Rise, Wisconsin Investment Partners.